Table 3.

Other treatments of patients in MEXCOVID study

	Treatment received				Oxygen support
	Antiviral treatment	Antibiotic or antifungal treatment	Corticosteroids treatment	Convalescent plasma transfusion	Before haMSCs-Exo nebulization	After haMSCs-Exo nebulization
Patient 1	Arbidol, ribavirin, IFN-α	Cefoperagone sodium and tazobactam sodium	None	Yes	Nasal cannula	Nasal cannula
Patient 2	Arbidol, ribavirin, IFN-α, lopinavir-ritonavir	Cefoperagone sodium and tazobactam sodium, meropenem	Methylprednisolone	Yes	Nasal cannula	Nasal cannula
Patient 3	Arbidol, IFN-alpha	None	None	None	Nasal cannula	Nasal cannula
Patient 4	Arbidol, oseltamivir	Cefoperagone sodium and tazobactam sodium, meropenem, moxifloxacin	Methylprednisolone	Yes	High-flow nasal cannula	Nasal cannula
Patient 5	IFN-α	Cefoperagone sodium and tazobactam sodium, meropenem	Methylprednisolone	Yes	Nasal cannula	Nasal cannula
Patient 6	Arbidol, IFN-α	Cefoperagone sodium and tazobactam sodium,	None	None	High-flow nasal cannula	Nasal cannula
Patient 7	Ganciclovir	Moxifloxacin, meropenem, fluconazole	None	None	Nasal cannula	Nasal cannula